Reaction Details |
| Report a problem with these data |
Target | Glycogen synthase kinase-3 beta |
---|
Ligand | BDBM314402 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | In Vitro Assay |
---|
IC50 | 1040±n/a nM |
---|
Citation | Alisi, MA; Cazzolla, N; Dragone, P; Furlotti, G; Maugeri, C; Ombrato, R; Mancini, F 1H-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitors US Patent US9611249 Publication Date 4/4/2017 |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Glycogen synthase kinase-3 beta |
---|
Name: | Glycogen synthase kinase-3 beta |
Synonyms: | GSK-3 beta | GSK-3, beta | GSK3B | GSK3B_HUMAN | Glycogen synthase kinase 3 beta (GSK3B) | Glycogen synthase kinase 3-beta (GSK3B) | Glycogen synthase kinase-3 beta (GSK-3B) | Glycogen synthase kinase-3 beta (GSK3 Beta) | Glycogen synthase kinase-3 beta (GSK3B) | Glycogen synthase kinase-3B (GSK-3B) | Glycogen synthase kinase-3beta (GSK3B) | Serine/threonine-protein kinase GSK3B |
Type: | Enzyme |
Mol. Mass.: | 46756.38 |
Organism: | Homo sapiens (Human) |
Description: | P49841 |
Residue: | 420 |
Sequence: | MSGRPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTK
VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSG
EKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHR
DIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDV
WSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHP
WTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALF
NFTTQELSSNPPLATILIPPHARIQAAASTPTNATAASDANTGDRGQTNNAASASASNST
|
|
|
BDBM314402 |
---|
n/a |
---|
Name | BDBM314402 |
Synonyms: | US9611249, Compound 33 | {4-[({[5-(3,6-dihydro-2H-pyran-4-yl)-1H- indazol-3-yl]carbonyl}amino)methyl] piperidin-1-yl}acetic acid |
Type | Small organic molecule |
Emp. Form. | C21H26N4O4 |
Mol. Mass. | 398.4555 |
SMILES | OC(=O)CN1CCC(CNC(=O)c2n[nH]c3ccc(cc23)C2=CCOCC2)CC1 |t:23| |
Structure |
|